[A cross-sectional study on HGV infection in a rural population].
OBJECTIVE
To determine the epidemiological characteristics and clinical significance of HGV infection, and to compare with HBV and HCV infections.


METHODS
Anti-HGV, HBsAg, anti-HBs, anti-HBc and anti-HCV were detected by enzyme-linked immunoassays (EIA). Anti-HGV positive sera were further tested for HGV RNA by a nested reverse transcription polymerase chain reaction (RT-nPCR).


RESULTS
The anti-HGV prevalence rate was 12.9%. It was relatively low in children under 10 years, and then increased with age and peaked in the group of 50-60 years of age (29.2%). The positive rate of HBsAg was 12.6%, and it quickly reached the highest (16.2%) in the 5-year old group. The prevalence rate of HBV infection was 64.9%, and increased to a high level in the group of 10 years of age, and maintained high up to 79.2% in the 50 years old group. The HCV infection rate was 15.3%. No anti-HCV positive cases were found in the group under 10 years of age. It was particularly high in the 20-40 years age group, and reached the peak in the group of 30 years old. No significant differences were found in the infection rates of HBV, HCV and HGV between male and female. HGV infection was associated with the history of blood donation, and the sexual transmission between couples. The anti-HGV positive rate of wives with anti-HGV positive husbands was 53.3%, significantly higher than that of those with anti-HGV negative husbands (7.8%). HGV coinfection with HBV or HCV had no influence on serum alanine aminotransferase (ALT). NO ALT elevation was found in the group with HGV infection alone.


CONCLUSIONS
The epidemiological characteristics of HGV infection are different from those of HBV and HCV. HGV is transmitted by blood and sex, and does not seem to cause liver damage.
Ling
B
B
Department of Microbiology, Beijing Medical University.
Zhuang
H
H
Cui
Y
Y
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002681:China / Q000453:epidemiology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D018067:Flaviviridae / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood; D006525:Hepatitis, Viral, Human / Q000453:epidemiology*; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012423:Rural Health
D006508:Hepatitis Antibodies